Header Logo

Connection

JORGE CASTILLO to Cytotoxicity, Immunologic

Back to Details
This is a "connection" page, showing publications JORGE CASTILLO has written about Cytotoxicity, Immunologic.
JORGE CASTILLO
Connection Strength
0.337
Cytotoxicity, Immunologic
  1. Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia. Expert Rev Anticancer Ther. 2011 Feb; 11(2):151-60.
    View in: PubMed
    Score: 0.337
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.